Onconetix Inc (ONCO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.15M
Last updated: Nov 17, 2026 at 4:40 PM ET
Onconetix Inc (ONCO) Statistics
Onconetix (ONCO) has a market cap of $2.15M. It holds $2.64M more cash than debt, 122.86% of its market cap.
Total Valuation
| Market Cap | $2.15M |
|---|---|
| Latest price (Nov 17, 2026) | $3.00 |
Key Dates
The next earnings report is expected on Nov 17, 2026, covering the quarter ending Sep 30, 2026.
| Next Earnings Date | Nov 17, 2026 (expected) |
|---|---|
| Last Earnings Date | Aug 13, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 99.74% over 52 weeks and trades 49.92% below its 50-day average.
| Beta (1Y) | 1.21 |
|---|---|
| 52-Week Change | -99.74% |
| 1-Month Change | -30.28% |
| 3-Month Change | -57.81% |
| 6-Month Change | -74.47% |
| Total Return (1Y) | -99.74% |
| Total Return (3Y CAGR) | -98.27% |
| Return vs SPY (1Y) | -111.32% |
| Max Drawdown (1Y) | -99.81% |
| Max Drawdown (3Y) | -100.00% |
| Sharpe Ratio (1Y) | -2.97 |
| Correlation with SPY (1Y) | 0.08 |
| 50-Day Average | $5.99 |
| 200-Day Average | $92.70 |
| 52-Week Range | $2.76 to $1,610.00 |
| RSI (14 Days) | 38.3 |
| Average Volume (20 Days) | 3.20M |
Financial Position
Current assets cover 1.47x current liabilities.
| Current Ratio | 1.47x |
|---|---|
| Quick Ratio | 1.43x |
| Interest Coverage | -699.75x |
Returns and Efficiency
Return on invested capital is 57.50% over the last 12 months.
| Return on Assets (ROA) | -212.54% |
|---|---|
| Return on Invested Capital (ROIC) | 57.50% |
| ROA (5Y Average) | -93.82% |
| Inventory Turnover | 0.58x |
| Receivables Turnover | 8.42x |
| Cash Conversion Cycle | -4300 days |
Scores
ONCO has an Altman Z-Score of -17.04, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -17.04 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Balance Sheet
| Cash and Equivalents | $2.74M |
|---|---|
| Total Debt | $99.25K |
| Net Cash | $2.64M |
| Net Cash Per Share | $6.35 |
Balance sheet as of Sep 30, 2026.
Stock Splits
The last split was a 1-for-10 reverse split on Nov 6, 2026.
| Last Split Date | Nov 6, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:10 |
Peer Position
Against 4 similar companies, ONCO has the highest P/S.
P/S RatioPeer median 0.8x
ROICPeer median -61.86%
| P/S Ratio | 2.8x vs 0.8x median |
|---|---|
| ROIC | 57.50% vs -61.86% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About ONCO
What is ONCO's market cap?
Onconetix has a market cap of $2.15M.
How many shares of ONCO are outstanding?
Onconetix has 416.12K shares outstanding.
Does ONCO pay a dividend?
No. Onconetix does not pay a dividend.
How much debt does ONCO have?
Onconetix has $99.25K of total debt and $2.74M of cash and equivalents, a net cash position of $2.64M.
ONCO pages: Overview, Charting, Financials, Statistics, Competitors